The comparison of chemerin, adiponectin and lipid profile indices in obese and non-obese adolescents

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 2, 2016, Pages S43-S46

  Maghsoudi, Zahra ^a   Kelishadi, Roya ^b   Hosseinzadeh Attar, Mohammad Javad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Adolescents; Chemerin; Lipid profile

Indexed keywords

ADIPONECTIN; CHEMERIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DISEASE ASSOCIATION; FAT MASS; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRUCTURAL EQUATION MODELING; ADIPOCYTE; BLOOD; IRAN; METABOLISM; RISK FACTOR;

ADIPOCYTES; ADIPONECTIN; ADOLESCENT; BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IRAN; LIPIDS; OBESITY; RISK FACTORS;

EID: 85027954934     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.01.020     Document Type: Article

References (26)

1. Goralski, K.B., McCarthy, T.C., Hanniman, E.A., Zabel, B.A., Butcher, E.C., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282 (2007), 28175–28188.
2. Kelishadi, R., Ardalan, G., Gheiratmand, R., Majdzadeh, R., Hosseini, M., Gouya, M.M., Thinness Health Dev, 2007, 144–154.
3. Gao, X., Mi, S., Zhang, F., Gong, F., Lai, Y., Gao, F., Zhang, X., et al. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol 10 (2011), 2–9.
4. Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Chemerin is a novel adipokine associated with obesity and metabolic syndrom. Endocrinology 148 (2007), 4687–4694.
5. Allen, S.J., Zabel, B.A., Kirkpatrick, J., Butcher, E.C., Nietlispach, D., NMR assignment of human chemerin, a novel chemottractant. Biomol NMR Assign 1 (2007), 171–173.
6. Takahashi, M., Takahashi, Y., Takahashi, K., Zolotaryov, F.N., Hong, K., Su, K.R., Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipose. Federation Eur Biochem Soc 582 (2008), 573–578.
7. Panagopoulou, P., Galli-Tsinopoulou, A., Fleva, A., Pavlitou-Tsiontsi, E., Vavatsi-Christaki, N., Nousia-Arvanitakis, S., Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 47:3 (2008), 356–362.
8. Trayhurn, P., Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184:4 (2005), 285–293.
9. Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation 102 (2000), 1296–1301.
10. Akbarpour, M., Alimardani, A., Sadeghyan, H., Assarzadeh, M., Relationship serum level of ghrelin with leptin and adiponectin in lean and obese adolescent. Intl J Basic Sci Appl Res 3:10 (2014), 688–694.
11. Izadi, M., Taghi Goodarzi, M., Samari Khalaj, H., Khorshidi, D., Doali, H., Serum adiponectin levels are inversely correlated with insulin resistance in obese men with type 2 diabetes. Int J Endocrinol Metab 9:1 (2011), 253–257.
12. Ozkan, B., Doneray, H., Keskin, H., The effect of vitamin D treatment on serum adiponectin levels in children with vitamin D deficiency rickets. J Clin Res Pediatr Endocrinol 1:6 (2009), 262–265.
13. Husain R, Yen Tan S. Body composition of healthy Malaysian adults using bioimpedance analysis. Proceedings of the 4th Asia-Oceania conference on obesity, February 9–11, 2007, Seoul, South Korea; 2007.
14. Bottner, A., Kratzsch, J., Muller, G., Kapellen, T.M., Bluher, S., Keller, E., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89:8 (2004), 4053–4061.
15. Doost Mohammadian, A., Dorosty, A., Mahmoodi, M., Yeganeh, H., The survey of the nutritional factors related to weight of girl adolescents. Iran J Nutr Food Sci, 2009, 51–56.
16. Punthakee, Z., Delvin, E.E., O'loughlin, J., Paradis, G., Levy, E., Platt, R.W., et al. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab 91:6 (2006), 2119–2125.
17. Lehrke, M., Becker, A., Greif, M., Stark, R., Laubender, R.P., von, Z.F., et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161:2 (2009), 339–344.
18. Stejskal, D., Karpisek, M., Hanulova, Z., Svestak, M., Chemerin is an independent marker of the metabolic syndrome in a Caucasian population—a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:2 (2008), 217–221.
19. Sell, H., Laurencikiene, J., Taube, A., Eckardt, K., Cramer, A., Horrighs, A., et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58:12 (2009), 2731–2740.
20. Bozaoglu, K., Segal, D., Shield, K.A., Cummings, N., Curran, J.E., Comuzzie, A.G., Mahaney, M.C., Rainwater, D.L., VandeBerg, J.L., MacCluer, J.W., Collier, G., Blangero, J., Walder, K., Jowett, J.J.B.M., Chemerin is assossiated with metabolic syndrom phenotype in a Mexican-Americanpopulation. J Clin Endocrinol Metab 94:8 (2009), 3085–3088.
21. Wagner, A., Oujaa, M., Platat, C., Schweitzer, B., Arveiler, D., Adiponectin is associated with lipid profile and insulin sensitivity in French adolescents. Diabetes 34 (2008), 465–471.
22. Vilkram, N.K., Misra, A., Pandey, R.M., Dwivedi, M., Luthra, K., Adiponectin, insulin resistance and C-reactive protein in Asian Indian adolescents. Metabolism 53:10 (2004), 1336–1341.
23. Valle, M., Martos, R., Gascon, F., Canete, R., Zafra, M.A., Morales, R., Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31:1 (2005), 55–62.
24. Weigert, J., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Wiest, R., et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72:3 (2010), 342–348.
25. Dong, B., Ji, W., Zhang, Y., Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50 (2011), 1093–1097.
26. Hah, Y.J., Kim, N.K., Kim, M.K., Kim, H.S., Hur, S.H., Yoon, H.J., et al. Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab J 35:3 (2011), 248–254.